Lakeside Holding (LSH) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
29 Nov, 2025Company overview and business model
U.S.-based cross-border supply chain solution provider focused on the Asia-Pacific market, operating through subsidiaries American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd.
Offers customized cross-border ocean and airfreight solutions, including freight consolidation, customs clearance, warehousing, and U.S. domestic ground transportation.
Serves over 300 customers, primarily logistics companies for e-commerce and manufacturers transporting goods from Asia to the U.S.
Operates major warehousing and distribution centers in Illinois and Texas, with a network of over 150 partner warehouses nationwide.
Strategic focus on the Asian market, with a significant portion of revenue from China and South Korea.
Financial performance and metrics
Fiscal year ended June 30, 2024: revenue of $18.3 million, up 42.3% from $12.9 million in 2023.
Gross profit for 2024 was $3.7 million, up from $2.6 million in 2023.
For the six months ended December 31, 2024, revenue decreased 15.4% to $7.7 million, with gross profit of $480,308, down from $1.7 million in the prior year period.
As of March 31, 2024, accounts receivable net of allowance was approximately $2.8 million.
Use of proceeds and capital allocation
Company will not receive proceeds from the resale of shares by the selling stockholder; proceeds from any cash exercise of warrants will go to the company.
No plans to pay dividends in the foreseeable future; earnings will be retained to finance business growth.
Latest events from Lakeside Holding
- Quarterly revenue surged 95% with new pharma sales, but net loss and credit risk remain concerns.LSH
H1 202619 Feb 2026 - Board seeks approval for director elections, capital structure changes, and a key subsidiary sale.LSH
Proxy Filing30 Jan 2026 - Shareholders are asked to approve director elections, capital structure changes, and a key subsidiary sale.LSH
Proxy Filing23 Jan 2026 - Proxy seeks approval for director elections, capital structure changes, and subsidiary sale.LSH
Proxy Filing12 Jan 2026 - Shareholders to vote on major capital, governance, and digital asset strategy changes.LSH
Proxy Filing2 Dec 2025 - Shareholders will elect five directors, with strong board independence and oversight.LSH
Proxy Filing2 Dec 2025 - IPO offers 1,250,000 shares plus over-allotment, led by Benchmark and Axiom, Nasdaq listing planned.LSH
Registration Filing30 Nov 2025 - Amendment updates IPO exhibits, outlines $1.4M expenses, and details management and indemnification.LSH
Registration Filing30 Nov 2025 - Registering 7.97M shares for resale, the company faces growth, risk, and compliance challenges.LSH
Registration Filing29 Nov 2025